Trellus Health plc

LSE TRLS.L

Trellus Health plc Shares (Diluted, Weighted) for the year ending December 31, 2023: 161,508,333

Trellus Health plc Shares (Diluted, Weighted) is 161,508,333 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Trellus Health plc Shares (Diluted, Weighted) for the year ending December 31, 2022 was 161,508,333, a 22.60% change year over year.
Trellus Health plc Shares (Diluted, Weighted) for the year ending December 31, 2021 was 131,734,028.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

LSE: TRLS.L

Trellus Health plc

CEO	Dr. Marla Cindy Dubinsky M.D.
IPO Date	May 31, 2021
Location	United States
Headquarters	44 South Broadway
Employees	31
Sector	Healthcare
Industries Telehealth Biotechnology Drugstores & Retail Pharmacies Pharmaceuticals Software-as-a-Service (SaaS)

Description

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

Key trends

Past 5 years